Breaking News, Promotions & Moves

Cytovance Biologics Appoints VP of Development

Dr. John Mott brings over 35 years of industry experience.

By: Contract Pharma

Contract Pharma Staff

Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), has promoted Dr. John Mott to vice president of development. Mott will serve on the Senior Leadership Team and report to Dr. Jesse McCool, CEO for Cytovance Biologics.   “I am very excited to welcome Dr. Mott to my Senior Leadership Team.  With over three decades of experience expressing proteins at several large pharma companies like Pfizer and CROs like Aragen, John is well equipped to le...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters